Title
P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells
Date Issued
01 November 2006
Access level
open access
Resource Type
journal article
Author(s)
Ricote M.
García-Tuñón I.
Fraile B.
Aller P.
Paniagua R.
Royuela M.
Centro de Investigaciones Biológicas
Abstract
Purpose: One of the most relevant aspects in cell death regulation is the signalling of apoptosis by the serine/threonine kinases MAPKs. The aim of this study was to investigate the effects of TNF-α stimulation on MAPK activation, and the pro- or anti-apoptotic role of these kinases in LNCaP and PC3 cells. Material and methods: Treatments were carried out using several TNF-α concentrations, as well as specific pharmacological inhibitors of MAPKs. Apoptosis rates were evaluated by DAPI staining and flow cytometry. MAPK phosphorylation/activation was measured by Western blot. Results: TNF-α induced apoptosis in a dose-dependent manner in LNCaP but not in PC3 cells. The MAPK inhibitors revealed that the apoptotic rate in LNCaP cells increased significantly following p38 inhibition. The kinase inhibitors failed to cause changes in apoptosis in PC3 cells. Conclusions: The potentiation of apoptosis by p38 inhibition points to this kinase as a possible target for the treatment of androgen-dependent prostatic cancer. © 2006 Springer Science + Business Media, LLC.
Start page
1969
End page
1975
Volume
11
Issue
11
OCDE Knowledge area
Medicina clínica
Scopus EID
2-s2.0-33750620041
PubMed ID
Source
Apoptosis
Resource of which it is part
Apoptosis
ISSN of the container
13608185
Source funding
Universidad de Alcalá
Sponsor(s)
Supported by grants from the Fondo de Investigaciones Sanitarias (PI020383) and University of Alcalá. Acknowledgements This work was supported by grants from Fondo de Investigaciones Sanitarias (PI020383) and the University of Alcalá.
Sources of information: Directorio de Producción Científica Scopus